GROUP 3 - IBD

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

encourage image

There's no tags or description

Looks like no tags are added yet.

22 Terms

1
New cards

Crohn’s disease (regional enteritis)

  • A chronic inflammatory disorder characterized by alternating periods of remission and exacerbation

  • Involves subacute or long-term inflammation of the GI tract that affects the full thickness of the bowel wall, known as a transmural lesion

  • Although it can affect any part of the GI tract, it most commonly involves the distal ileum and ascending colon


2
New cards
  • RLQ abdominal pain

  • Diarrhea

  • Crampy abdominal pain (especially after meals)

  • Abdominal tenderness and spasm

  • Decreased food intake (weight loss, malnutrition, secondary anemia)

  • Steatorrhea

  • Abdominal and anal abscesses, fistulas, anal fissures


Clinical manifestations of Crohn’s disease

3
New cards
  • Family history of IBD (first-degree relative)

  • Female sex

  • Age 20-29

  • Caucasian ethnicity

  • Ashkenazi Jewish background

  • Living in a northern climate and urban area

  • Current smoker

  • Exposure to environmental triggers (air pollutants)

  • Abnormal or excessive cell-mediated immune response


Etiology/risk factors of Crohn’s disease

4
New cards
  • Chronic diarrhea, RLQ abdominal pain, post-meal cramping, fatigue, and weight loss

  • Assess appetite, weight, malnutrition, dehydration, and electrolyte imbalance

  • Abdominal distention and perianal lesions or fistulas. Assess bowel sounds. Assess tympany and abnormal dullness. Check for RLQ tenderness, guarding, or masses

  • Strictures, obstruction, fistulas, abscesses, and perforation


Key assessments of Crohn’s disease

5
New cards
  • Assess abdominal pain, bowel movement, and sounds. Monitor vital signs, weight, intake and output, and signs of dehydration

  • Assess nutritional status and monitor laboratory values such as CBC, electrolytes, and albumin

  • Encourage small, frequent meals, and adequate fluid intake


Nursing management of Crohn’s disease

6
New cards
  • Nutritional support through a high-calorie, high-protein diet when tolerated

  • Vitamin and mineral supplementation, especially iron, vitamin B12, vitamin D, and calcium

  • Enteral nutrition or Total Parenteral Nutrition may be needed in severe cases


Medical management of Crohn’s disease

7
New cards

Aminosalicylates (5-ASA), such as Mesalamine and Sulfasalazine

[PHARMACOLOGICAL MANAGEMENT OF CROHN’S]

Used to reduce intestinal inflammation, particularly in mild disease

8
New cards

Corticosteroids (Prednisone and Budesonide)

[PHARMACOLOGICAL MANAGEMENT OF CROHN’S]

Prescribed during acute flare ups, but are not recommended for long-term maintenance because of adverse effects

9
New cards

Immunomodulators (Azathioprine, 6-Mercaptopurine, and Methotrexate)

[PHARMACOLOGICAL MANAGEMENT OF CROHN’S]

Helps suppress the immune response and maintain remission

10
New cards

Biologic agents (Infliximab, Adalimumab)

[PHARMACOLOGICAL MANAGEMENT OF CROHN’S]

Used for moderate to severe disease that does not respond to conventional therapy

11
New cards

Antibiotics (Metronidazole, Ciprofloxacin)

[PHARMACOLOGICAL MANAGEMENT OF CROHN’S]

May be prescribed when fistulas, abscesses, or bacterial infections are present

12
New cards
  • Diet

  • Foods to limit or avoid if triggering symptoms

  • Hydration

  • Medication

  • Symptom monitoring

  • When to seek help

  • Lifestyle


Health education for Crohn’s disease

13
New cards

Ulcerative colitis

  • A chronic inflammatory condition affecting the mucosal and submucosal layers of the colon and rectum

  • Characterized by unpredictable periods of remission and exacerbation, often accompanied by abdominal cramping and bloody or pus-containing diarrhea

  • The inflammation usually starts in the rectum and gradually extends upward through the colon


14
New cards
  • Diarrhea with mucus, pus, or blood

  • LLQ abdominal pain

  • Intermittent tenesmus

  • Rectal bleeding (anemia, fatigue, pallor)

  • Abdominal cramping


Clinical manifestations of ulcerative colitis

15
New cards
  • Family history of IBD (first-degree relative)

  • Male sex

  • Age 15-30 and > 60 years old

  • Caucasian ethnicity

  • Ashkenazi Jewish background

  • Living in a northern climate and urban area

  • Former smoker or non-smoker

  • Exposure to environmental triggers (air pollutants)

  • Abnormal or excessive cell-mediated immune response


Etiology/risk factors of ulcerative colitis

16
New cards
  • Bloody diarrhea with mucus, LLQ abdominal pain, urgency, tenesmus, and fatigue.

  • Assess for weight loss, anemia, dehydration, and electrolyte imbalance.

  • Assess for pallor and abdominal distention. Assess bowel sounds. Assess for tympany and abnormal distention. Check for LLQ tenderness, guarding, or rigidity.

  • Toxic megacolon, severe hemorrhage, and perforation.


Key assessments for ulcerative colitis

17
New cards
  • Monitor stool frequency, consistency, and the presence of blood or mucus. Assess abdominal pain, bowel sounds, and abdominal tenderness.

  • Monitor hydration status, intake and output, daily weight, and electrolyte levels. Encourage adequate fluid intake and provide a low-residue diet during flare-ups. Promote adequate rest to reduce fatigue

  • Administer prescribed medications and monitor for side effects. Educate the patient about medication adherence, dietary modifications, stress reduction, and recognizing signs of worsening disease.


Nursing management for ulcerative colitis

18
New cards
  • Provide nutritional support with adequate calories and protein. Correct fluid and electrolyte imbalances caused by diarrhea.

  • Blood transfusion may be necessary for severe bleeding and anemia.

  • Surgery may be recommended for severe disease, toxic megacolon, perforation, or colorectal cancer.


Medical management for ulcerative colitis

19
New cards

Aminosalicylates (5-ASA) (Mesalamine, Sulfasalazine)

[PHARMACOLOGICAL MANAGEMENT FOR ULCERATIVE COLITIS]

Are the first-line treatment for mild to moderate ulcerative colitis

20
New cards

Immunomodulators (Azathioprine, 6-Mercaptopurine)

[PHARMACOLOGICAL MANAGEMENT FOR ULCERATIVE COLITIS]

Are prescribed to maintain remission and reduce corticosteroid dependence

21
New cards

Biologic agents (Infliximab, Adalimumab, Vedolizumab, and Ustekinumab)

[PHARMACOLOGICAL MANAGEMENT FOR ULCERATIVE COLITIS]

Are indicated for moderate to severe ulcerative colitis that is unresponsive to conventional treatment

22
New cards
  • Diet

  • Foods to limit

  • Hydration

  • Medication adherence

  • Bowel monitoring

  • When to seek help

  • Colon health and follow-up


Health education for ulcerative colitis